Longeveron Inc. Files 2024 10-K Report
Ticker: LGVN · Form: 10-K · Filed: Feb 28, 2025 · CIK: 1721484
Sentiment: neutral
Topics: 10-K, annual-report, biopharmaceutical
TL;DR
Longeveron filed its 2024 10-K. Check financials and future plans.
AI Summary
Longeveron Inc. filed its 2024 10-K report on February 28, 2025, detailing its fiscal year ending December 31, 2024. The company, based in Miami, FL, operates in the pharmaceutical preparations sector. The filing covers various aspects of its business, including financial performance, risk factors, and corporate governance, as it navigates the development and commercialization of its therapeutic candidates.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Longeveron's financial health, operational activities, and strategic outlook for the fiscal year 2024, crucial for understanding the company's trajectory in the biopharmaceutical industry.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Longeveron faces inherent risks related to drug development, regulatory approvals, and market adoption, which are detailed within the filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the financial statements in the 10-K.)
- 2025-02-28 — Filing Date (The date Longeveron Inc. submitted its 10-K to the SEC.)
Key Players & Entities
- Longeveron Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- 2025-02-28 (date) — Filing date of the 10-K
- Miami, FL (location) — Company headquarters
- Pharmaceutical Preparations (industry) — Company's Standard Industrial Classification
FAQ
What is Longeveron Inc.'s primary business activity as indicated by its SIC code?
Longeveron Inc.'s primary business activity is in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When did Longeveron Inc. file its 10-K report for the fiscal year ending December 31, 2024?
Longeveron Inc. filed its 10-K report for the fiscal year ending December 31, 2024, on February 28, 2025.
Where is Longeveron Inc. headquartered?
Longeveron Inc. is headquartered in Miami, FL, with its business and mailing address at 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL 33136.
What was the SEC file number for Longeveron Inc.'s 10-K filing?
The SEC file number for Longeveron Inc.'s 10-K filing is 001-40060.
What is the fiscal year end for Longeveron Inc.?
Longeveron Inc.'s fiscal year end is December 31 (1231).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding Longeveron Inc. (LGVN).